MakeMyTrip confidentially files for India IPO of local subsidiary via offer for sale
Nasdaq-listed MakeMyTrip has confidentially filed a pre-filed DRHP with SEBI, BSE and NSE to list its Indian subsidiary through an offer for sale. The move targets stronger domestic brand visibility and a fungible dual-market listing structure.
What happened
Nasdaq-listed MakeMyTrip confidentially filed a pre-filed DRHP with SEBI, BSE and NSE for the IPO of its Indian subsidiary via an offer for sale, aiming to
Why this matters
MakeMyTrip's fungible dual-market listing sets a precedent for Nasdaq-listed India subsidiaries to unlock domestic valuation—monitor as a template for carve-out and re-listing strategies.
What to watch
- Public DRHP filing with valuation band and OFS quantum
- Trip.com / major holder stake-sale disclosures
- SEBI approval or query rounds
- Indian IPO market sentiment and grey-market premium
- Q-on-Q domestic travel booking volume data
- Monitor MakeMyTrip investor calls for OFS size, selling shareholders (Trip.com stake reduction likely) and use-of-listing rationale
- Track SEBI observations and public DRHP conversion timeline
- Benchmark against listed Indian travel peers (ixigo, EaseMyTrip, Yatra) for pricing signals
- Assess Nasdaq ADS reaction to domestic float dilution narrative